BioSpace News Archive

Business

Electromed, Inc. Schedules Release of First Quarter Fiscal 2018 Financial Results and Conference Call

Electromed announced that it will issue its financial results press release for the fiscal 2018 first quarter ended September 30, 2017 on Tuesday, November 7, 2017 after the close of the stock market.

October 25, 2017

·

1 min read

Biotech Bay

Grant of Share Options to Directors, PDMRs and Employees and Grant of Restricted Stock Units to Summit Therapeutics’ Non-Executive Directors

The Company has also made a grant of restricted stock units (‘RSUs’) to the Non-Executive Directors under the Company’s 2017 Remuneration Policy.

October 25, 2017

·

9 min read

Medtronic Announces First Economic Analysis Demonstrating Benefits of Professional CGM in People With Type 2 Diabetes

Data from the study demonstrated significant cost avoidance to the healthcare system when used during a therapy change or when used at least twice per year.

October 25, 2017

·

4 min read

Pharm Country

BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials

First to market alliance increases precision and specificity while reducing cost .

October 25, 2017

·

5 min read

Pharm Country

Tyme Identifies Potential Method and Biomarker for Converting Malignant Tumors to Inert Calcified Mass

During clinical evaluation of Tyme’s lead candidate, it was observed that subsequent to SM-88 therapy some lytic bone lesions converted to benign sclerotic bone.

October 25, 2017

·

5 min read

Quotient Scores $40M and Eyes an Additional $49M

Quotient will use the cash to fund the ongoing development and commercial scale up and, if approved, commercialization of MosaiQ.

October 25, 2017

·

3 min read

Business

Iovance Biotherapeutics to Host Conference Call to Discuss Third Quarter 2017 Financial Results and Provide a Corporate Update on Tuesday, October 31, 2017

Management will host a conference call and live audio webcast to discuss these results and provide a corporate update at 4:30 p.m. ET.

October 25, 2017

·

1 min read

Drug Development

Atara Biotherapeutics Announces Six of Ten Progressive Multiple Sclerosis (MS) Patients Experienced Clinical Improvements in an Ongoing Phase I Study of Autologous ATA190

Six of ten progressive MS patients in the Phase 1 study of autologous ATA190 (formerly known as autologous ATA188) experienced clinical improvements.

October 25, 2017

·

10 min read

Business

Conatus Pharmaceuticals to Report Third Quarter 2017 Financial Results

The company will report financial results for the third quarter ended September 30, 2017, after the market close on Wednesday, November 1, 2017.

October 25, 2017

·

2 min read

Genetown

FieldLab 58 Portable Fluid Analysis System From Spectro Scientific Boosts Performance with New X-ray Fluorescence (XRF) Engine

Spectro Scientific has introduced an upgrade to its FieldLab 58 consisting of a more powerful X-ray fluorescence (XRF) module and newly designed filter that significantly improve the limits of detection for wear metal elements in oil.

October 25, 2017

·

3 min read